My NCBI | Sign In
RSS Settings
  • Search:

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 269

    1.

    Mechanism of improvement in glucose metabolism after chronic glyburide therapy.

    Simonson DC, Ferrannini E, Bevilacqua S, Smith D, Barrett E, Carlson R, DeFronzo RA.

    Diabetes. 1984 Sep;33(9):838-45.PMID: 6432610 [PubMed - indexed for MEDLINE]Related articles

    2.

    Effect of glyburide on glycemic control, insulin requirement, and glucose metabolism in insulin-treated diabetic patients.

    Simonson DC, Delprato S, Castellino P, Groop L, DeFronzo RA.

    Diabetes. 1987 Feb;36(2):136-46.PMID: 3100365 [PubMed - indexed for MEDLINE]Related articles

    3.

    Oral sulfonylurea agents suppress hepatic glucose production in non-insulin-dependent diabetic individuals.

    DeFronzo RA, Simonson DC.

    Diabetes Care. 1984 May-Jun;7 Suppl 1:72-80.PMID: 6428844 [PubMed - indexed for MEDLINE]Related articles

    4.

    Effects of glyburide on in vivo insulin-mediated glucose disposal.

    Simonson DC.

    Am J Med. 1990 Aug 20;89(2A):44S-50S; discussion 51S-53S.PMID: 2117389 [PubMed - indexed for MEDLINE]Related articles

    5.

    Metabolic effects of metformin on glucose and lactate metabolism in noninsulin-dependent diabetes mellitus.

    Cusi K, Consoli A, DeFronzo RA.

    J Clin Endocrinol Metab. 1996 Nov;81(11):4059-67.PMID: 8923861 [PubMed - indexed for MEDLINE]Related articles

    6.

    Mechanism of metformin action in obese and lean noninsulin-dependent diabetic subjects.

    DeFronzo RA, Barzilai N, Simonson DC.

    J Clin Endocrinol Metab. 1991 Dec;73(6):1294-301.PMID: 1955512 [PubMed - indexed for MEDLINE]Related articles

    7.

    Concomitant insulin and sulfonylurea therapy in patients with type II diabetes. Effects on glucoregulation and lipid metabolism.

    Osei K, O'Dorisio TM, Falko JM.

    Am J Med. 1984 Dec;77(6):1002-9.PMID: 6439036 [PubMed - indexed for MEDLINE]Related articles

    8.

    The acute and chronic effects of sulfonylurea therapy in type II diabetic subjects.

    Kolterman OG, Gray RS, Shapiro G, Scarlett JA, Griffin J, Olefsky JM.

    Diabetes. 1984 Apr;33(4):346-54.PMID: 6423429 [PubMed - indexed for MEDLINE]Related articles

    9.

    Recovery of Staub Effect and amelioration of insulin secretion defects after glyburide treatment in non-insulin-dependent diabetes.

    Soneru IL, Hein N, Jeffery JD, Abraira C.

    Diabetes Res. 1990 Oct;15(2):77-83.PMID: 2132401 [PubMed - indexed for MEDLINE]Related articles

    10.

    Effects of basal insulin supplementation on disposition of mixed meal in obese patients with NIDDM.

    McMahon M, Marsh HM, Rizza RA.

    Diabetes. 1989 Mar;38(3):291-303.PMID: 2492963 [PubMed - indexed for MEDLINE]Related articles

    11.

    How does glibenclamide lower plasma glucose concentration in patients with type 2 diabetes?

    Jeng CY, Hollenbeck CB, Wu MS, Chen YD, Reaven GM.

    Diabet Med. 1989 May-Jun;6(4):303-8.PMID: 2524334 [PubMed - indexed for MEDLINE]Related articles

    12.

    Fasting hyperglycemia in non-insulin-dependent diabetes mellitus: contributions of excessive hepatic glucose production and impaired tissue glucose uptake.

    DeFronzo RA, Ferrannini E, Simonson DC.

    Metabolism. 1989 Apr;38(4):387-95.PMID: 2657323 [PubMed - indexed for MEDLINE]Related articles

    13.

    The effect of insulin treatment on insulin secretion and insulin action in type II diabetes mellitus.

    Garvey WT, Olefsky JM, Griffin J, Hamman RF, Kolterman OG.

    Diabetes. 1985 Mar;34(3):222-34.PMID: 3882489 [PubMed - indexed for MEDLINE]Related articles

    14.

    Quantification of the relative impairment in actions of insulin on hepatic glucose production and peripheral glucose uptake in non-insulin-dependent diabetes mellitus.

    Campbell PJ, Mandarino LJ, Gerich JE.

    Metabolism. 1988 Jan;37(1):15-21.PMID: 3275857 [PubMed - indexed for MEDLINE]Related articles

    15.

    Assessment of insulin sensitivity and secretion with the labelled intravenous glucose tolerance test: improved modelling analysis.

    Mari A.

    Diabetologia. 1998 Sep;41(9):1029-39.PMID: 9754821 [PubMed - indexed for MEDLINE]Related articles

    16.

    Different effects of glyburide and glipizide on insulin secretion and hepatic glucose production in normal and NIDDM subjects.

    Groop L, Luzi L, Melander A, Groop PH, Ratheiser K, Simonson DC, DeFronzo RA.

    Diabetes. 1987 Nov;36(11):1320-8.PMID: 3117609 [PubMed - indexed for MEDLINE]Related articles

    17.

    Hepatic and peripheral insulin resistance: a common feature of type 2 (non-insulin-dependent) and type 1 (insulin-dependent) diabetes mellitus.

    DeFronzo RA, Simonson D, Ferrannini E.

    Diabetologia. 1982 Oct;23(4):313-9.PMID: 6754515 [PubMed - indexed for MEDLINE]Related articles

    18.

    In vivo action of glibenclamide in obese subjects with mild type 2 (non-insulin dependent) diabetes.

    Hother-Nielsen O, Schmitz O, Andersen PH, Pedersen O, Beck-Nielsen H.

    Diabetes Res. 1988 Jun;8(2):63-70.PMID: 3147830 [PubMed - indexed for MEDLINE]Related articles

    19.

    Improved glycemic control and enhanced insulin sensitivity in type 2 diabetic subjects treated with pioglitazone.

    Miyazaki Y, Mahankali A, Matsuda M, Glass L, Mahankali S, Ferrannini E, Cusi K, Mandarino LJ, DeFronzo RA.

    Diabetes Care. 2001 Apr;24(4):710-9.PMID: 11315836 [PubMed - indexed for MEDLINE]Related articlesFree article

    20.

    Continuous subcutaneous insulin infusion therapy decreases insulin resistance in type 1 diabetes.

    Yki-Järvinen H, Koivisto VA.

    J Clin Endocrinol Metab. 1984 Apr;58(4):659-66.PMID: 6365945 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Filter your results:

    Find related data

    Recent activity